SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the approaching FDA decision on Capricors deramiocel for Duchenne muscular dystrophy, with traders weighing the companys amended application and longer-term upper-limb data alongside recent FDA discussion of flexibility in rare-disease reviews. Many are bullish and read commercial hiring as a sign of launch preparation, while skeptics stress that approval is uncertain given the earlier negative review and debate over the evidence; some also cite Inovios separate FDA approval as a positive sentiment signal.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A push to a fresh 52-week high is drawing attention ahead of an expected Q3 earnings update, while traders debate whether the rally reflects business momentum, short-covering, or speculation about an unconfirmed buyout.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of a competing treatment for recurrent respiratory papillomatosis has raised concerns about new competition for Precigens PAPZIMEOS. Traders debate the threat: some see a serious challenge, while others argue Precigen retains an advantage from its commercial head start and full approval, and view the selloff as an overreaction.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas stronger-than-expected quarterly results and raised outlook, alongside growing interest in identity security for AI agents, have driven a sharp rally. Traders are divided between seeing durable cybersecurity demand and warning that the move has outrun the companys growth, with valuation concerns and profit-taking weighing on shares.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that Medicare reimbursement for DefenCath could decline after early 2027 has fueled concerns about pricing and CorMedixs largest revenue driver. Traders are divided: some see the comments as a serious commercial risk, while others argue DaVitas outlook is preliminary and point to CMSs reimbursement estimate as a counterweight.

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Mineralys Therapeutics Inc

MLYS is under pressure amid concerns that the slow early commercial ramp for AstraZenecas competing hypertension drug could signal a challenging launch and weaker near-term sales prospects for lorundrostat. Traders disagree on whether that undermines Mineralyss commercial outlook, with some emphasizing the upcoming FDA decision and clinical data while others question its ability to compete independently.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff and fresh lows ahead of its earnings report are driving attention, with analyst price-target cuts and concerns about advertising demand adding pressure. Traders are split between viewing the decline as excessive given the companys growth and profitability, and worrying that weaker ad-market signals or an earnings disappointment could prolong the slide.

BNB (BNB) is a cryptocurrency . BNB has a current supply of 131,511,396.41. The last known price of BNB is 698.79071116 USD and is down -6.08 over the last 24 hours. It is currently trading on 3523 active market(s) with $4,017,835,584.29 traded over the last 24 hours. More information can be found at https://bnbchain.org/en.

Binance

A reported major Binance security breach, with withdrawals temporarily suspended and billions in crypto reportedly affected, is driving attention to BNB and broader crypto-market concerns. Traders are debating whether the incident threatens trust in Binance and warrants further selling, while others view the selloff as an overreaction; claims of an inside job remain speculation.

Permian Resources Corp. is an oil and natural gas company, which focuses on returns to stakeholders through the responsible acquisition, optimization and development of crude oil and associated liquids-rich natural gas reserves. The company was founded on December 18, 2025 and is headquartered in Midland, TX.

Permian Resources Holdings Inc. - Ordinary Shares - Class A

Permian Resources Corp - Ordinary Shares - Class A

Permian Resources is being discussed amid volatile crude prices and shifting Middle East supply risks, especially tensions and shipping disruptions around the Strait of Hormuz. Traders debate why PR often fails to track oils moves, while some point to the companys production growth, guidance and dividends as support for a longer-term bullish view.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

Centruss steep selloff is the dominant topic, with traders citing share dilution and the cost and execution risks of expanding enrichment capacity, alongside weakness across nuclear stocks. Bulls point to its strategic U.S. HALEU supply role and government contracts as long-term support, while others question the valuation and whether the decline has further to run.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?

Cronos Group stock climbs 17% in three months on strong revenue growth and margin gains, but rising competition and regulatory risks raise questions about its upside.

VFF Stock Up 49% in Three Months: Is the Rally Sustainable?

Village Farms' 49% three-month surge is fueled by stronger European cannabis demand and rising profitability, but margin normalization and competition loom.

Village Farms International Names Hamid Shekarchi Interim CFO

(RTTNews) - Thursday, Village Farms International, Inc. (VFF, VFF.TO) announced that it has appointed Hamid Shekarchi as interim Chief Financial Officer, effective immediately...

Village Farms (VFF) Q2 Earnings and Revenues Beat Estimates

Village Farms (VFF) delivered earnings and revenue surprises of +200.00% and +13.99%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Apyx Medical (APYX) Reports Q2 Loss, Beats Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of -16.67% and +10.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Aurora Cannabis Inc. (ACB) Q1 Earnings and Revenues Beat Estimates

Aurora Cannabis (ACB) delivered earnings and revenue surprises of +130.77% and +4.89%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

AtriCure (ATRC) Q2 Earnings and Revenues Top Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of +500.00% and +1.39%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

VFF Stock Loses 27% in Three Months: Time to Invest or Exit?

Village Farms has slid 27% in three months despite strong international cannabis growth. Can European expansion outweigh rising competition and pricing risks?

Why Is VFF Stock Falling Today?

Equity

The company said it entered into securities purchase agreements to sell 7.5 million shares in a registered direct offering.

Village Farms International Q1 Earnings Call Highlights

Village Farms International Q1 Earnings Call Highlights...

Village Farms International, Inc. engages in the management and operation of agricultural greenhouse facilities in the United States and Canada. It operates through the following segments: Canadian Cannabis, U.S. Cannabis, Produce, Energy, and Leli. The Canadian Cannabis segment includes Pure Sunfarms and Rose LifeScience. The U.S. Cannabis segment operates Balanced Health. The Produce segment involves producing, marketing, and distribution of tomatoes. The Energy segment owns and operates power plants from landfill gas that generates electricity and provides thermal heat. The Leli segment produces and supplies cannabis products to designated coffee shops. The company was founded by Michael A. DeGiglio and Albert W. Vanzeyst in 1987 and is headquartered in Lake Mary, FL.

Village Farms International Inc

Bearish Sentiment

<ul class="summary-bullets"><li>Village Farms stated that the investment by two institutional investors had not been previously contemplated.</li><li>The company expects gross proceeds of about $15 million from the offering.</li><li>At the end of the first quarter, Village Farms had $55 million in cash, and the company continues to expect its cash balance to grow.</li></ul>Shares of Village Farms International Inc. (VFF) were down over 4% on Friday after&nbsp;the cannabis and plant-based consumer packaged goods company announced a $15 million registered direct equity investment from two new U.S. institutional capital partners. Village Farms stated that the investment by two institutional investors had not been previously contemplated.The company said it&nbsp;entered into securities purchase agreements for the sale of 7.5 million shares in a registered direct offering, with gross proceeds expected at about $15 million before deducting placement agent fees and other expenses.“While our balance sheet does not require a capital infusion, we took this opportunity as we believe it will enhance the strength of our cap table and welcome institutional capital partners of very high caliber who will support our future growth,”&nbsp;said&nbsp;Michael DeGiglio, President and Chief Executive Officer of Village Farms.Net proceeds from the offering are intended for working capital and general corporate purposes. The offering is expected to close on or about June 8, 2026, subject to customary conditions. Upon closing, the company will have more than 121 million issued and outstanding common shares, Village Farms stated.<h2 class="st-heading-2">A Snapshot Of VFF’s Cash Positions At Q1-End</h2>At the end of the first quarter, Village Farms had $55 million in cash, and the company continues to expect to grow its cash balance through positive operating cash flow for the remainder of 2026.However, during the first-quarter earnings call, the management stated that the impact of the large Canadian corporate income taxes in the first quarter (Q1) resulted in negative cash flow from operations of $16.8 million, while the Q1 cash flow from cannabis operations was negative $11.8 million.<h2 class="st-heading-2">What Does VFF Do?</h2>Village Farms is a global cannabis operator with over seven million square feet of greenhouse and indoor cultivation assets across Canada, the Netherlands, and international markets.It runs the world's largest EU-GMP certified cannabis facility in British Columbia, and is one of only ten licensed operators in the Netherlands' regulated cannabis program.&nbsp;The company also sells cannabinoid wellness products in the U.S. through its CBDistillery brand, and holds cannabis equity stakes in Australia and Germany. It also operates a clean energy division that converts landfill gas into renewable natural gas.<h2 class="st-heading-2">What Retail Thinks Of VFF</h2>On Stocktwits, retail sentiment surrounding the stock has remained ‘bearish’ among ‘low’ message volumes in the past 24 hours.&nbsp;<a href="https://stocktwits.com/symbol/VFF">VFF stock</a> has declined by more than 33% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/kevin-hassett-fed-watch-inflation-wait-before-rate-action-may-jobs-report/cZ0FZbwReCQ">Hassett Says Fed Can Watch Inflation Numbers And Wait Before Rate Action: 'This Is About The Strongest Market Of My Lifetime'</a>

Close-up of fresh cannabis plant on sunny day. Natural pattern is on green leaf. Organic hemp is growing at farm.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$2.50
Prev Close	$2.59
Open	$2.56
Dividend Yield	0.00%
50-Day Moving Average	$2.80
Beta	1.25
Avg. Volume	743,845.74
PE Ratio	13.92

52-Week High	$4.99
52-Week Low	$1.81
Market Capitalization	$316.72M
EPS (Annual)	$0.1051
Price to Book	1.01
Revenue Per Employee	$191,433.51

Feed

News

Sentiment

Earnings

Fundamentals

Info

VFF Fundamentals